Holdings of the Fund as of 3/28/2024
Total Number of Holdings (excluding cash): 51
Masimo Corporation |
MASI |
574795100 |
649 |
$95,305.65 |
2.98% |
DexCom, Inc. |
DXCM |
252131107 |
660 |
$91,542.00 |
2.86% |
Shockwave Medical, Inc. |
SWAV |
82489T104 |
261 |
$84,989.43 |
2.66% |
Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
622 |
$77,707.19 |
2.43% |
Terumo Corporation |
4543.JP |
J83173104 |
4,060 |
$74,010.77 |
2.31% |
Intuitive Surgical, Inc. |
ISRG |
46120E602 |
184 |
$73,432.56 |
2.30% |
Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
255 |
$72,710.90 |
2.27% |
ResMed Inc. |
RMD |
761152107 |
358 |
$70,894.74 |
2.22% |
Stryker Corporation |
SYK |
863667101 |
195 |
$69,784.65 |
2.18% |
Boston Scientific Corporation |
BSX |
101137107 |
1,015 |
$69,517.35 |
2.17% |
Waters Corporation |
WAT |
941848103 |
199 |
$68,501.77 |
2.14% |
Cochlear Limited |
COH.AU |
Q25953102 |
310 |
$68,182.72 |
2.13% |
GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
748 |
$68,000.68 |
2.13% |
Edwards Lifesciences Corporation |
EW |
28176E108 |
711 |
$67,943.16 |
2.12% |
Baxter International Inc. |
BAX |
071813109 |
1,579 |
$67,486.46 |
2.11% |
Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
496 |
$66,890.34 |
2.09% |
Agilent Technologies, Inc. |
A |
00846U101 |
454 |
$66,061.54 |
2.07% |
Insulet Corporation |
PODD |
45784P101 |
379 |
$64,960.60 |
2.03% |
Demant A/S |
DEMANT.DC |
K3008M105 |
1,293 |
$64,146.35 |
2.01% |
Mettler-Toledo International Inc. |
MTD |
592688105 |
48 |
$63,901.92 |
2.00% |
Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
481 |
$63,482.38 |
1.99% |
Abbott Laboratories |
ABT |
002824100 |
553 |
$62,853.98 |
1.97% |
Amplifon SpA |
AMP.IM |
T0388E118 |
1,726 |
$62,938.99 |
1.97% |
Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
4,063 |
$62,263.81 |
1.95% |
Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
391 |
$62,431.68 |
1.95% |
The Cooper Companies, Inc. |
COO |
216648501 |
616 |
$62,499.36 |
1.95% |
Align Technology, Inc. |
ALGN |
016255101 |
189 |
$61,976.88 |
1.94% |
Veralto Corporation |
VLTO |
92338C103 |
700 |
$62,062.00 |
1.94% |
Siemens Healthineers AG |
SHL.GY |
D6T479107 |
1,008 |
$61,682.09 |
1.93% |
Hoya Corporation |
7741.JP |
J22848105 |
494 |
$61,465.46 |
1.92% |
Medtronic Plc |
MDT |
G5960L103 |
699 |
$60,917.85 |
1.91% |
Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
208 |
$60,219.35 |
1.88% |
Danaher Corporation |
DHR |
235851102 |
240 |
$59,932.80 |
1.87% |
Teleflex Incorporated |
TFX |
879369106 |
265 |
$59,935.05 |
1.87% |
Thermo Fisher Scientific Inc. |
TMO |
883556102 |
103 |
$59,864.63 |
1.87% |
BioMerieux |
BIM.FP |
F1149Y232 |
520 |
$57,362.62 |
1.79% |
Penumbra, Inc. |
PEN |
70975L107 |
256 |
$57,134.08 |
1.79% |
Hologic, Inc. |
HOLX |
436440101 |
729 |
$56,832.84 |
1.78% |
Alcon Inc. |
ALC.SW |
H01301128 |
670 |
$55,525.66 |
1.74% |
Olympus Corporation |
7733.JP |
J61240107 |
3,840 |
$55,135.25 |
1.72% |
Smith & Nephew Plc |
SN/.LN |
G82343164 |
4,377 |
$54,780.18 |
1.71% |
DENTSPLY SIRONA Inc. |
XRAY |
24906P109 |
1,630 |
$54,099.70 |
1.69% |
Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
2,670 |
$53,595.27 |
1.68% |
Exact Sciences Corporation |
EXAS |
30063P105 |
771 |
$53,245.26 |
1.67% |
Sysmex Corporation |
6869.JP |
J7864H102 |
2,934 |
$52,089.13 |
1.63% |
West Pharmaceutical Services, Inc. |
WST |
955306105 |
130 |
$51,442.30 |
1.61% |
Steris Plc |
STE |
G8473T100 |
226 |
$50,809.32 |
1.59% |
Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
145 |
$50,151.15 |
1.57% |
Revvity, Inc. |
RVTY |
714046109 |
475 |
$49,875.00 |
1.56% |
Becton, Dickinson and Company |
BDX |
075887109 |
195 |
$48,252.75 |
1.51% |
WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
3,978 |
$18,856.05 |
0.59% |
US Dollar |
$USD |
|
7,720 |
$7,719.96 |
0.24% |
Australian Dollar |
$AUD |
|
564 |
$367.63 |
0.01% |
Pound Sterling |
$GBP |
|
0 |
$0.06 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|